Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    14991374 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
An Open-Label Trial of Tocilizumab in Schizophrenia
Condition: Schizophrenia
Intervention: Drug: Tocilizumab
2 Recruiting Siltuximab in Schizophrenia
Conditions: Schizophrenia;   Psychotic Disorders
Interventions: Drug: Siltuximab;   Drug: normal saline

Study has passed its completion date and status has not been verified in more than two years.